AVIRON
S-3/A, EX-23.1, 2000-11-30
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: AVIRON, S-3/A, EX-5.1, 2000-11-30
Next: NEW WORLD COFFEE MANHATTAN BAGEL INC, DEF 14A, 2000-11-30



<PAGE>   1

                                                                    EXHIBIT 23.1


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in
Amendment No. 2 to the Registration Statement (Form S-3) and related Prospectus
of Aviron for the registration of 1,124,872 shares of its common stock and to
the incorporation by reference therein of our report dated February 17, 2000,
with respect to the financial statements of Aviron included in its Annual
Report (Form 10-K/A) for the year ended December 31, 1999 filed with the
Securities and Exchange Commission.

                                                       /s/ Ernst & Young LLP


Palo Alto, California
November 28, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission